Chiechi L Mario
University of Bari, Department of Obstetrics and Gynecology, Corso Alcide de Gasperi 495, 70125 Bari, Italy.
IDrugs. 2004 Sep;7(9):860-4.
Novovax Inc has developed and launched Estrasorb, a transdermally absorbed, micro-encapsulated estradiol, as an estrogen replacement therapy for short-term use in the reduction of vasomotor symptoms in menopausal women. Estrasorb was launched in the US in April 2004.
诺华克斯公司已研发并推出了依思芮（Estrasorb），一种经皮吸收的微囊化雌二醇，作为一种雌激素替代疗法，用于短期减轻绝经后女性的血管舒缩症状。依思芮于2004年4月在美国上市。
